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Abstract
Background: The structural and functional differences between hepatitis B virus (HBV) genotypes are the mainstay
to severity, complications, treatment and possibly vaccination against the virus. This study was conducted to
determine the HBV genotypes in HBsAg positive patients of Afghanistan as no such large scale data available
previously.
Methods: Two hundred and fourteen HBsAg-positive patients were included in this study. All patients were anti-
HCV and anti-HIV negative. All the samples were confirmed for HBV DNA with nested PCR while HBV DNA positive
samples were subjected to type specific PCR for HBV genotyping (A-F).
Results: Of the total samples, 168 (78.5%) were males and 46 (21.49%) females, aged ranged between 18 to 71
years. This study demonstrated that genotype D (35.67%) is the predominant genotype circulating in Afghani’s
population. Genotype C was observed in 32.16% followed by genotype A (19.30%), and genotype B (7.02%) while
6.07% of the individuals were not typed.
Conclusion: This study has shown a heterogeneous distribution of HBV genotypes. Further more, extensive studies
are required to investigate genetic and geographical divergence and characteristics of the virus in the country, as
no such large sample sized study has been carried out so far in this country.
Background
Hepatitis B virus (HBV) infects nearly two billion people
worldwide [1], cause approximately 600,000 deaths
annually due to acute and chronic consequences [2].
HBV is classified into eight genotypes, from A to H,
based on an intra-group nucleotide divergence of up to
4.2% of the S-genome sequences or in >8% of the entire
genome sequences [1-5], which consists of about 3200
base pairs [5]. These genotypes arise during replication
as a result of nucleotide mis-incorporations, in the
absence of any proofreading capacity by the viral poly-
merase [1]. HBV exhibits genetic variability with an esti-
mated rate of 1.4 - 3.2 × 10
-5 nucleotide substitution
per site per year [6].
A greater demand for genotyping of patient strains of
HBV are growing as specific clinical associations with
each genotype becomes increasingly apparent [5]. HBV
genotypic determination is of particular importance for
the study of the detection of the virus’s origin, course of
evaluating HBV, the severity and activity of liver disease
[1,4,5], prognosis and response to antiviral treatment
[1,3], patterns of serological reactivity and replication of
the virus [1]. Recent studies demonstrated that a parti-
cular genotype may affect clinical manifestations during
the course of the disease. As patients affected by geno-
type A have a better prognosis, genotype B enhances the
possibility of hepatic malignancy [4], genotype C is asso-
ciated with faster liver damage than genotype B [2], ala-
nine transaminase level and the index of inflammatory
cellular necrosis in genotype C was higher than in geno-
type B [2], genotype D may develop fulminant hepatitis
with high frequency [4,5], may be more associated with
liver cirrhosis compared to A [2,5], whereas genotype F
was found to be associated with severe infection and
young hepatocellular carcinoma development which was
found to be more associated with higher mortality rates
as compared to other genotypes [2,6].
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dle East, a recognized geographical region of southwes-
tern Asia. It’s bordered by the countries of China,
Pakistan, Iran, Turkmenistan, Uzbekistan and Tajikistan.
Over the last three decades of conflict, approximately
eight million Afghans have been displaced in neighbor-
ing counties. Since 2002, over five million refugees have
returned, predominately from Pakistan (3.2 million) and
Iran (1.8 million). During conflict and displacement,
social networks and services are often disrupted, which
may alter sexual behaviors and access to services. In
Afghanistan relatively large percentage of young men
are in the police force and/or military [7] and are truck
drivers, who are frequently away from home for
extended periods. Furthermore, refugees may have
acquired high-risk behavior, such as injection drug use
and unsafe paid sex [8]. The immigration of populations
from neighboring countries of high endemic of the
infection (particularly Pakistan and Iran) seems to con-
tribute significantly to the rapid modification of epide-
miological data of viral hepatitis and may place other
communities at risk upon their return [9]. This study
was designed to determine and analyze the distribution
of HBV genotypes among patients with hepatitis B sur-
face antigen (HBsAg) from Afghanistan. Additional
objectives were to determine whether there was an asso-
ciation of HBV genotypes with neighboring countries
including Pakistan, Iran and China.
Materials and methods
Study Samples
A total of 214 patients with HBsAg positivity were
included in this study and written consent was not
taken because all the investigations done in this
research were routinely for all hepatitis patients,
beside no patients identification (name or number)
where mentioned in this research. All the blood sam-
ples were collected from the Infectious Disease Hospi-
tal Kabul, Central Blood Bank Kabul and Central
Laboratory Kabul Afghanistan, approved by the ethical
committee. Sera were separated and stored at -20°C in
Directorate of Legal Medicines Kabul Afghanistan and
then transported in cold boxes to the Molecular Para-
sitology and Virology Laboratory, Department of Zool-
ogy, Kohat University of Science and Technology
Kohat, Pakistan for further processing. All the samples
were analyzed for the detection of HBV DNA and
HBV genotyping.
HBV DNA DETECTION
DNA Extraction
DNA was extracted from 100 μl of serum by of GF-1
nucleic acid extraction kit (Vivantas USA) according to
the manufacturer procedure with minimal alterations.
DNA Amplification
PCR reactions were carried out in a thermal cycler
(Nyxtech USA) with 5UTaq DNA polymerase (Fermen-
tas USA). The first round of amplification was per-
formed with 5 μl of extracted DNA by using an outer
sense primer and an outer antisense primer specific to
the surface gene of HBV. Another round of PCR was
carried out with inner sense primer and inner antisense
primer. Amplified products were subjected to electro-
phoresis in 2% agarose gel and evaluated under UV
transillumination. The 185bp specific amplified HBV
DNA product was determined by comparing with the
50-bp DNA ladder (Fermantas USA), used as DNA size
marker.
HBV Genotyping
HBV genotypes were performed as described by Naito et
al., 2001.
Results
A total of 214 HBs Ag positive individuals with mean
age 37.5 ± 11.14 years including 168 (78.5%) men and
46 (21.49%) women age ranged (18 to 71 years) were
investigated for HBV DNA presence. Of the total, 138
male and 31 female were confirmed HBV DNA carrier
while in 30 male and 15 female HBV DNA was not
detected. HBV genotype distribution in 169 HBV DNA
positive Afghani patients is shown in Table 1.
In this study HBV infection in HBs Ag-positive
patients (n = 214) were attributed predominantly to
viral genotype D constituted 35.67% (n = 61) of the
total HBV DNA positive individuals. The prevalence of
other HBV genotypes in the study population were like
that genotype C was 32.16% (n = 55), genotype B was
7.02% (n = 12), genotype A was 19.30% (n = 33), geno-
type was not observed in about 3.73% (n = 8) of patients
while genotype E, genotype F and mixed genotype was
found in none of them Figure 1.
Discussion
Limited prevalence data for HBV exist for Afghanistan.
Overall prevalence of HBV was recorded 6.15% in
injecting drug users [10,11], 6.54% in female sex workers
[12], 1.53% in obstetric patients and 1.76% in blood
donors [9]. HBV genotypes have different biological and
epidemiological behavior [5]. Since they influence the
Table 1 HBV genotype distribution in HBV DNA Positive
Afghani Patients (n = 169)
Gender Genotype
A B C D Not typed
Male 30 9 48 45 6
Female 3371 62
Total 33(19.53%) 12(7.10%) 55(32.54%) 61(36.09%) 8(4.73%)
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disease, as well as the response to antiviral therapies
[3-5], their detection and monitoring is more than just
academic but also medically significant. Therefore HBV
genotyping become a routine exercise in clinical medi-
cine and molecular epidemiology [5]. Since several geno-
types HBV are very closely associated with the severity,
development of sever liver diseases (cirrhosis and hepa-
tocellular carcinoma) and antiviral therapy. Detection of
HBV genotypes is also very important to clarify the
pathogenesis, route of infection and virulence of the
virus [1].
HBV genotypes and subgenotypes are known to have
a distinct pattern of geographic distribution. Mass of
evidences showed that genotype A is most common in
northwest Europe and the United States, genotypes B
and C prevail in Asia, genotype D has a worldwide dis-
tribution but predominates in the Mediterranean area,
genotype E has been reported from western and South-
east Africa, genotype F has been detected in South and
Central America [1,3]. To date, the isolation of genotype
G has been limited to HBV carriers in France, Germany,
United Kingdom, Italy and the United States of America
[1] and Genotype H has been described only recently,
and its distribution is not understood yet [13].
This study will provide useful information for treat-
ment and management of HBV infection in Afghanistan
where there is no such large scale molecular based
study of disease has done before. An epidemiologic
study with sufficient participants in a wide age range is
necessary to address this issue [18]. In this regard the
only study published in January 2006 has reported the
only genotype among hepatitis B infected patients from
Afghanistan was genotype D while other genotypes were
not reported [19]. Their study, however, investigated
small sample size (n = 12) and therefore, their results
cannot be generalized for all Afghanistan population. In
our study obtained results for genotype D (35.67%) was
similar to other reports from other countries of Middle
East area. The most important finding in our results
was the nearly equal predominance of the genotype C
(32.16%) followed by genotype A that constituted
19.30%. The difference in both studies probably due to
the age of the HBV-infected subjects as HBV DNA
tends to fluctuate with time [18]. Discrepancy may be
correlated to the difference in sensitivity between the
two methods used. In other words, sequence analysis
provides information only on the majority strain [5]. In
this study sensitive technique was used for genotyping,
where the distribution of HBV genotype by using PCR
technique was also representative for HBV carriers with
low viremia and does not have bias even if levels of vire-
mia would be different among genotypes [18].
High HBV prevalence has reported among Afghan
refugee populations outside of Afghanistan than that
reported among Afghan blood donors [9]. Mass immi-
gration and illegal drug traffic from Pakistan and Iran
have all affected epidemiology in Afghanistan [8].
Furthermore, it may be noted that injection drug abuse
is common in these countries [10,11] and, thus, could
often be the mode of transmission of HBV. IDUs often
trade sex for drugs and therefore particularly vulnerable
to HBV [8,10]. However, there is a dearth of studies
comparing genotypes with these countries. Therefore,
present study population provided with a unique oppor-
tunity to compare these genotypes.
In Asia, research on genotyping, was initially con-
ducted extensively in Japan and China, therefore, the
genotypes of these countries namely B and C were con-
sidered as the most prevalent genotypes of Asia. Later
on, when research was extended to other countries, pre-
dominance of genotype D was found in South Asia and
the Middle East including India, Afghanistan and Iran
[16]. HBV genotypes show a characteristic geographic
distribution with a proposed association with human
migration. It is interested to note that Arians firstly
colonized to the North of the Caspian Sea, then
migrated to Iran, India and Europe. It might be those
people who acquired the virus with the genotype D
before their migration and then transmitted the virus
generation by generation after their migration. That’s
why the dominant genotype in India, Iran and most part
of the Europe is D [17]. History of population migration
from the Middle East to Pakistan is also well known,
which explains the predominance of genotype D infec-
tion in this population [16].
In countries with high levels of immigration, a variety
of genotypes are being reported as all of the known gen-
otypes can be found in the Europe and North America
[18]. The presence of genotypes A and D also reflected
the immigrant origins of the population of Buenos
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Figure 1 HBV genotype distribution in HBsAg positive Afghani
patients (n = 214).
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received immigration from the Mediterranean area
(Afghanistan, Iran, Pakistan, Egypt etc), where genotype
D predominates. Thus, we should expect genotype D
rather than A to be prevalent. It has been suggested that
genotype D may have replaced genotype A in the Medi-
terranean area [19].
In fact genotyping can help to trace the migration of
ancestors as well as the routes of transmission in acci-
dental exposure to HBV [20]. A study of 39 asympto-
matic HBV carriers and 103 liver diseases patients from
southern China showed circulation of A, B, C, and D
genotypes with 78.9% being genotype C [13]. However,
in Pakistanis 62% were genotype D, A (14%), C (6%),
other genotypes (4%) and recombination (10%). Interest-
ingly, no genotype other than D has been found in Iran.
The epidemiological data about HBV genotypes in var-
ious Asian countries demonstrated the presence of all
seven genotypes, particularly the pre-dominance of gen-
otype D [17]. This close relationship between Afghani-
stan and neighbouring countries demonstrated a
circulation of closely related viruses. Future studies are
needed to carry out work on the prevalence of HBV
genotypes and sub genotypes across the Afghanistan
and compare it to the neighboring countries. At the
same time, current crisis in Afghanistan has resulted in
an influx of Western military personnel, peacekeepers,
humanitarian workers, and journalists [21].
Conclusions
To be successful, HBV prevention, treatment and vacci-
nation strategies must be based on a sound understand-
ing of the genotypes and epidemiological behavior of
the virus, especially in those geographic regions where
there no genotype base study has done. It was con-
cluded that HBV genotype demonstrated significant
divergence now. In order to shed more light on this
subject further investigations are needed to fully unravel
the mystery of the prevalence of HBV genotypes all
across the Afghanistan to reach a decision concerning
their clinical utility.
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